Skip to content
Screener

OptimizeRx OPRX Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$3.27M+5.9%$3.4M+4.6%————$3.09M—
$5.53M-5.7%$4.73M-5.1%————$5.87M—
$20.59M-20.8%$19.45M-19.1%————$25.99M—
-$703K-146%-$495K+77.5%$5.02M+6,536%$779K+109%$1.53M+138%
-$0.04-150%-$0.03+75.0%$0.26—$0.04+108%$0.08+136%
$976K-77.2%$1.46M+245%$9.65M—$3.13M+142%$4.28M+260%
-$88K-103%$396K+119%$8.57M—$2.05M+124%$3.21M+186%

FAQ

What is OptimizeRx's revenue?
OptimizeRx (OPRX) generated $98.7M in revenue over the trailing twelve months, down 5.8% year over year.
Is OptimizeRx profitable?
OptimizeRx reported $4.6M in net income over the trailing twelve months, a 4.7% net margin.
What are OptimizeRx's profit margins?
Gross margin is 73.2% and operating margin is 11.1%, with a 4.7% net margin.
What is OptimizeRx's earnings per share?
OptimizeRx's diluted EPS over the trailing twelve months is $0.23.
Where does OptimizeRx's income statement data come from?
Every line is extracted from OptimizeRx's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.